Justin Haught, MD
Dermatology · Richmond, VANPI 1912101312
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $652 of the $852 with a category attached, or 76.5%. 9 manufacturers reported payments, led by Johnson & Johnson at 24.9% of the total. 2025 is the largest year on record at $395, more than ten times the $17 reported in 2021. That places this record below the midpoint for dermatology clinicians in VA, where the typical reported total is $1,785.
Across 24 payments — averaging $35.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$212
- Sun Pharmaceutical Industries Inc.$157
- UCB, Inc.$125
- Regeneron Healthcare Solutions, Inc.$115
- Sanofi$103
- Galderma Laboratories, L.p.$57
- plus $83 from 3 others
What the payments were for
- Food & beverage$65277%
- Education$20023%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 2 | $212 |
| Sun Pharmaceutical Industries Inc. | 8 | $157 |
| UCB, Inc. | 1 | $125 |
| Regeneron Healthcare Solutions, Inc. | 2 | $115 |
| Sanofi | 4 | $103 |
| Galderma Laboratories, L.p. | 3 | $57 |
| Smith+Nephew | 2 | $51 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $17 |
| Pfizer | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$852 in reported general payments places this provider in the 35th percentile of 396 dermatology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 35 | $311,055 |
| EnbrelEtanercept | 19 | $235,427 |
| Cosentyx Sensoready (2 Pens)Secukinumab | 30 | $217,386 |
| Dupixent PenDupilumab | 45 | $196,626 |
| Taltz AutoinjectorIxekizumab | 18 | $115,030 |
| OtezlaApremilast | 21 | $108,694 |
| Humira PenAdalimumab | 11 | $74,838 |
| Clobetasol Propionate | 371 | $14,964 |
| Tretinoin | 87 | $9,072 |
| Metronidazole | 52 | $4,581 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 65 | $4,072 |
| Clindamycin Phosphate | 103 | $3,696 |
| Ammonium Lactate | 149 | $3,574 |
| Triamcinolone Acetonide | 183 | $3,313 |
| Doxycycline Hyclate | 72 | $3,078 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Richmond
- Mohammed DanyRichmond$74K
- Suzanne PeckRichmond$51K
- Melissa KingRichmond$15K
- Victoria GrossRichmond$14K
- Margaret TerhuneRichmond$13K
- Naiem IssaVienna$2M
- Saurabh SinghFairfax$1.7M
- Diego DasilvaVirginia Beach$1.1M
- Vishal PatelLeesburg$719K
- Cyndi Torosky TommasoVirginia Beach$717K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.